Compare HUIZ & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUIZ | UG |
|---|---|---|
| Founded | 2006 | 1942 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 27.7M |
| IPO Year | 2020 | N/A |
| Metric | HUIZ | UG |
|---|---|---|
| Price | $3.21 | $6.20 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 12.6K |
| Earning Date | 03-24-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 11.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.25 | ★ 0.43 |
| Revenue | ★ $186,519,166.00 | $10,060,322.00 |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | ★ $12.65 | $14.35 |
| Revenue Growth | ★ 19.12 | N/A |
| 52 Week Low | $1.50 | $5.58 |
| 52 Week High | $4.53 | $11.98 |
| Indicator | HUIZ | UG |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 51.16 |
| Support Level | $3.04 | $6.08 |
| Resistance Level | $3.58 | $6.25 |
| Average True Range (ATR) | 0.28 | 0.11 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 21.88 | 74.00 |
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.